Loading live market data…

Artiva Biotherapeutics, Inc.

NASDAQ:ARTV

$9.35 USD

$0.42 (4.7%)

Volume
432.58K
Average Volume
618.56K
Market Capitalization
$231.11M
P/E Ratio
-2.63
Dividend Yield
0.00%
Price Target
$37.50
Year High
$14.53
Year Low
$2.07
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$8.16

ARTV Estimated and Actual Revenue by Quarter

ARTV Estimated and Actual EPS by Quarter

ARTV Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2030-12-31 1 -37.47M -37.47M -37.47M -38.39M -38.39M -38.39M
2030-09-30 2 -29.52M -29.52M -29.52M -30.25M -30.25M -30.25M
2030-06-30 2 -21.08M -21.08M -21.08M -21.6M -21.6M -21.6M
2030-03-31 1 -12.58M -12.58M -12.58M -12.89M -12.89M -12.89M
2029-12-31 2 -6.6M -6.6M -6.6M -6.76M -6.76M -6.76M
2029-09-30 1 -2.03M -2.03M -2.03M -2.08M -2.08M -2.08M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2030-12-31 1 3.51M 3.51M 3.51M 1.1B 1.1B 1.1B
2030-09-30 2 -1.57M -1.57M -1.57M 863.01M 863.01M 863.01M
2030-06-30 2 -6.94M -6.94M -6.94M 616.29M 616.29M 616.29M
2030-03-31 1 -12.33M -12.33M -12.33M 367.7M 367.7M 367.7M
2029-12-31 2 -15.99M -15.99M -15.99M 192.84M 192.84M 192.84M
2029-09-30 1 -18.4M -18.4M -18.4M 59.38M 59.38M 59.38M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2030-12-31 1 67.95M 67.95M 67.95M 1 0.1424 0.1424 0.1424
2030-09-30 2 53.54M 53.54M 53.54M 1 -0.0638 -0.0638 -0.0638
2030-06-30 2 38.23M 38.23M 38.23M 1 -0.2811 -0.2811 -0.2811
2030-03-31 1 22.81M 22.81M 22.81M 1 -0.4995 -0.4995 -0.4995
2029-12-31 2 11.96M 11.96M 11.96M 1 -0.648 -0.648 -0.648
2029-09-30 1 3.68M 3.68M 3.68M 1 -0.7455 -0.7455 -0.7455